These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1467107)

  • 21. [Problems in massive transfusion].
    Eckart J; Schaaf H
    Infusionsther Klin Ernahr; 1978 Dec; 5(6):346-52. PubMed ID: 363619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of massive transfusion during liver transplantation on rejection and infection.
    Rouch DA; Thistlethwaite JR; Lichtor L; Emond JC; Broelsch CE
    Transplant Proc; 1988 Dec; 20(6):1135-7. PubMed ID: 3059596
    [No Abstract]   [Full Text] [Related]  

  • 23. Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy.
    Seghatchian J; Samama MM
    Transfus Apher Sci; 2012 Oct; 47(2):235-43. PubMed ID: 22770808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aprotinin on coagulation parameters in liver transplantation.
    Welte M; Groh J; Azad S; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):297-9. PubMed ID: 7689755
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemorrhage and coagulopathy in the critically ill.
    Paterson TA; Stein DM
    Emerg Med Clin North Am; 2014 Nov; 32(4):797-810. PubMed ID: 25441035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive blood transfusion therapy.
    Corazza ML; Hranchook AM
    AANA J; 2000 Aug; 68(4):311-4. PubMed ID: 11125603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for intraoperative massive transfusion in pediatric liver transplantation: a multivariate analysis.
    Jin SJ; Kim SK; Choi SS; Kang KN; Rhyu CJ; Hwang S; Lee SG; Namgoong JM; Kim YK
    Int J Med Sci; 2017; 14(2):173-180. PubMed ID: 28260994
    [No Abstract]   [Full Text] [Related]  

  • 28. Correction of blood coagulation dysfunction and anemia by supplementation of red blood cell suspension, fresh frozen plasma, and apheresis platelet: results of in vitro hemodilution experiments.
    Li L; Yang J; Sun Y; Dang Q; Xu C; Chen P; Ma T; Ren J
    J Crit Care; 2015 Feb; 30(1):220.e1-12. PubMed ID: 25316528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraoperative blood transfusion requirements and deficient hemostasis in highly alloimmunized patients undergoing liver transplantation.
    Marino IR; Weber T; Esquivel CO; Kang YG; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1988 Dec; 20(6):1087-9. PubMed ID: 3059590
    [No Abstract]   [Full Text] [Related]  

  • 30. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.
    Hardy JF; De Moerloose P; Samama M;
    Can J Anaesth; 2004 Apr; 51(4):293-310. PubMed ID: 15064258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management.
    Callum JL; Rizoli S
    Hematology Am Soc Hematol Educ Program; 2012; 2012():522-8. PubMed ID: 23233629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective statistical analysis of coagulation parameters after 250 liver transplantations.
    Gerlach H; Slama KJ; Bechstein WO; Lohmann R; Hintz G; Abraham K; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):223-32. PubMed ID: 8362252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation disorders in acute renal failure.
    Schetz MR
    Kidney Int Suppl; 1998 May; 66():S96-101. PubMed ID: 9573583
    [No Abstract]   [Full Text] [Related]  

  • 34. Massive transfusion and nonsurgical hemostatic agents.
    Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
    Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic problems after massive blood transfusions].
    Wendt M; Lawin P; Götz E
    Infusionsther Klin Ernahr; 1979 Dec; 6(6):325-9. PubMed ID: 396253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status.
    Frasco PE; Poterack KA; Hentz JG; Mulligan DC
    Anesth Analg; 2005 Jul; 101(1):30-7, table of contents. PubMed ID: 15976201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A guide to blood groups, transfusion and coagulation.
    Sharp S
    Br J Perioper Nurs; 2004 Jan; 14(1):16-20. PubMed ID: 14768122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iTACTIC - implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial.
    Baksaas-Aasen K; Gall L; Eaglestone S; Rourke C; Juffermans NP; Goslings JC; Naess PA; van Dieren S; Ostrowski SR; Stensballe J; Maegele M; Stanworth SJ; Gaarder C; Brohi K; Johansson PI
    Trials; 2017 Oct; 18(1):486. PubMed ID: 29047413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood coagulation disorders in massive blood transfusion].
    Otteni JC; Haberer JP; Hug P; Oberling F
    Zentralbl Chir; 1975; 100(22):1352-63. PubMed ID: 1202857
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience].
    Agnes S; Avolio AW; Magalini SC; Foco M; Gattavilla N; Castagneto M; Crucitti F
    Minerva Chir; 1992 Mar; 47(6):473-9. PubMed ID: 1589097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.